202 related articles for article (PubMed ID: 29868450)
1. Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease.
Freeze B; Acosta D; Pandya S; Zhao Y; Raj A
Neuroimage Clin; 2018; 18():456-466. PubMed ID: 29868450
[TBL] [Abstract][Full Text] [Related]
2. Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
Freeze B; Pandya S; Zeighami Y; Raj A
Brain; 2019 Oct; 142(10):3072-3085. PubMed ID: 31359041
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
5. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
Mao X; Ou MT; Karuppagounder SS; Kam TI; Yin X; Xiong Y; Ge P; Umanah GE; Brahmachari S; Shin JH; Kang HC; Zhang J; Xu J; Chen R; Park H; Andrabi SA; Kang SU; Gonçalves RA; Liang Y; Zhang S; Qi C; Lam S; Keiler JA; Tyson J; Kim D; Panicker N; Yun SP; Workman CJ; Vignali DA; Dawson VL; Ko HS; Dawson TM
Science; 2016 Sep; 353(6307):. PubMed ID: 27708076
[TBL] [Abstract][Full Text] [Related]
6. Predictive model of spread of Parkinson's pathology using network diffusion.
Pandya S; Zeighami Y; Freeze B; Dadar M; Collins DL; Dagher A; Raj A
Neuroimage; 2019 May; 192():178-194. PubMed ID: 30851444
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
Olsen AL; Feany MB
Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.
Lin X; Parisiadou L; Gu XL; Wang L; Shim H; Sun L; Xie C; Long CX; Yang WJ; Ding J; Chen ZZ; Gallant PE; Tao-Cheng JH; Rudow G; Troncoso JC; Liu Z; Li Z; Cai H
Neuron; 2009 Dec; 64(6):807-27. PubMed ID: 20064389
[TBL] [Abstract][Full Text] [Related]
9. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.
Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R
Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735
[TBL] [Abstract][Full Text] [Related]
11. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
12. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive delivery of an α-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound.
Xhima K; Nabbouh F; Hynynen K; Aubert I; Tandon A
Mov Disord; 2018 Oct; 33(10):1567-1579. PubMed ID: 30264465
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
15. Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes.
Banwinkler M; Dzialas V; ; Hoenig MC; van Eimeren T
Mov Disord; 2022 Oct; 37(10):2066-2074. PubMed ID: 35943058
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
17. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.
Limegrover CS; Yurko R; Izzo NJ; LaBarbera KM; Rehak C; Look G; Rishton G; Safferstein H; Catalano SM
J Neurosci Res; 2021 Apr; 99(4):1161-1176. PubMed ID: 33480104
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia.
Obi T; Nishioka K; Ross OA; Terada T; Yamazaki K; Sugiura A; Takanashi M; Mizoguchi K; Mori H; Mizuno Y; Hattori N
Neurology; 2008 Jan; 70(3):238-41. PubMed ID: 18195271
[No Abstract] [Full Text] [Related]
20. Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.
Gazzina S; Premi E; Turrone R; Acosta-Cabronero J; Rizzetti MC; Cotelli MS; Gasparotti R; Padovani A; Borroni B
J Neurol; 2016 Aug; 263(8):1575-82. PubMed ID: 27230856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
